<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Abnormal uterine bleeding in adolescents: Evaluation and approach to diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Abnormal uterine bleeding in adolescents: Evaluation and approach to diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Abnormal uterine bleeding in adolescents: Evaluation and approach to diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nirupama K De Silva, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amy B Middleman, MD, MPH, MS Ed</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mitchell E Geffner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 23, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Abnormal uterine bleeding (AUB) refers to uterine bleeding in a nonpregnant female that is abnormal in volume, frequency, duration, and/or regularity [<a href="#rid1">1</a>].</p><p>The evaluation of common causes of AUB in adolescents will be discussed here. The management of AUB in adolescents and a more comprehensive discussion of the evaluation of AUB in older reproductive-age females are presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/117.html" rel="external">"Abnormal uterine bleeding in adolescents: Management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3263.html" rel="external">"Abnormal uterine bleeding in nonpregnant reproductive-age patients: Terminology, evaluation, and approach to diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">NORMAL MENSTRUAL CYCLE IN ADOLESCENTS</span><span class="headingEndMark"> — </span>The normal menstrual cycle results from a complex feedback system involving the hypothalamus, pituitary, ovary, and uterus  (<a class="graphic graphic_figure graphicRef62189" href="/z/d/graphic/62189.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H2294323280"><span class="h2">Timing and flow</span><span class="headingEndMark"> — </span>Menstrual cycles vary considerably during the first few years after menarche given irregularities in ovulation. The majority of cycles in adolescents last 21 to 45 days with two to seven days of menstrual bleeding  (<a class="graphic graphic_figure graphicRef79925" href="/z/d/graphic/79925.html" rel="external">figure 2</a>) [<a href="#rid2">2-5</a>]. The average adult menstrual cycle lasts 28 days to 35 days with four to six days of menstrual bleeding. The median blood loss during each menstrual period is 30 mL; the upper limit of normal is 80 mL. (See  <a class="medical medical_review" href="/z/d/html/7418.html" rel="external">"Normal menstrual cycle"</a>.)</p><p>In a systematic review of observational studies describing menstruation during the first year after menarche, the mean cycle length was 34.5 days (range 32 to 61) and decreased throughout the year [<a href="#rid6">6</a>]. Mean bleeding duration ranged from 4.9 to 5.4 days; bleeding of ≥7 days' duration occurred in 2 to 11 percent of cycles.</p><p class="headingAnchor" id="H2458061680"><span class="h2">Establishing ovulatory cycles</span><span class="headingEndMark"> — </span>The duration of time that it takes to establish regular ovulatory cycles increases with increasing age at the time of menarche [<a href="#rid6">6-8</a>]. One-half of cycles are ovulatory by one year in females with menarche at &lt;12 years, by three years in females with menarche between 12 and 13 years, and by 4.5 years in females with menarche at ≥13 years [<a href="#rid7">7</a>]. (See <a class="local">'Anovulatory uterine bleeding'</a> below.)</p><p>In the first year or two after menarche, all adolescent females are prone to anovulatory cycles in which the endometrium lacks the stabilizing effect of progesterone. In such cycles, the endometrium becomes excessively thickened. It breaks down and sloughs when estrogen is withdrawn (estrogen-withdrawal bleeding) or when it becomes unstable (estrogen-breakthrough bleeding) [<a href="#rid9">9</a>].</p><p>Adolescents with regular menses have cyclic estrogen secretion that permits orderly growth and shedding of the endometrium (estrogen-withdrawal bleeding), even in the absence of ovulation. In addition, when ovulatory cycles do occur, they are associated with increased progesterone secretion, which helps to stabilize endometrial growth and permits more complete shedding [<a href="#rid10">10</a>].</p><p>Adolescents with irregular menses and anovulatory bleeding appear to have delayed maturation or dysfunction of the hypothalamic-pituitary-ovarian axis. In these adolescents, the midcycle surge of luteinizing hormone does not occur and estrogen secretion is sustained in the absence of progesterone [<a href="#rid10">10,11</a>]. The endometrium proliferates beyond the ability of estrogen to maintain it. Irregular, heavy bleeding occurs when the endometrium becomes unstable (estrogen-breakthrough bleeding) and continues until estrogen-induced repair takes place [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3"><span class="h1">TERMINOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>AUB</strong> – AUB refers to menstrual bleeding that occurs outside the normal range, and includes [<a href="#rid1">1,2,12</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Absence of menses (amenorrhea)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Menses at irregular intervals</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For adolescents, menstrual periods more frequently than every 21 days or less frequently than every 45 days [<a href="#rid2">2</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Excessive in duration (ie, &gt;7 days)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heavy menstrual bleeding, defined subjectively as a volume of menstrual flow that interferes with quality of life (physical, emotional, social, and/or material) [<a href="#rid1">1,13</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intermenstrual or breakthrough bleeding</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anovulatory uterine bleeding</strong> – "Anovulatory uterine bleeding" is the preferred term for heavy noncyclic uterine bleeding unrelated to structural lesions of the uterus, systemic disease, or sexually transmitted infection [<a href="#rid14">14</a>]. This pattern of bleeding was previously called "dysfunctional uterine bleeding." In the FIGO classification system, anovulatory uterine bleeding is classified as a type of ovulatory dysfunction [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CAUSES OF VAGINAL BLEEDING IN ADOLESCENTS</span><span class="headingEndMark"> — </span>Adolescents with AUB typically present with a complaint of abnormal "vaginal bleeding." The uterus is the most likely source of vaginal bleeding  (<a class="graphic graphic_table graphicRef62751" href="/z/d/graphic/62751.html" rel="external">table 1</a>). Other sources include the ovary, cervix, vagina, vulva, gastrointestinal tract, and urinary tract. Nonuterine sources of vaginal bleeding are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5440.html" rel="external">"Causes of female genital tract bleeding"</a> and  <a class="medical medical_review" href="/z/d/html/15411.html" rel="external">"Evaluation of vulvovaginal bleeding in children and adolescents"</a>.)</p><p>Heavy bleeding is typically from the uterus, whereas light bleeding, staining, or spotting may be from any site along the genital tract. Postcoital bleeding suggests bleeding from the cervix or other lower genital tract source. Bleeding that occurs solely with urination or defecation suggests a urinary or gastrointestinal source. (See  <a class="medical medical_review" href="/z/d/html/3263.html" rel="external">"Abnormal uterine bleeding in nonpregnant reproductive-age patients: Terminology, evaluation, and approach to diagnosis", section on 'Gynecologic and obstetric history'</a>.)</p><p>The most common cause of AUB in adolescents during the initial one to two years of menstruation are anovulatory cycles, which are related to immaturity of the hypothalamic-pituitary-ovarian axis [<a href="#rid3">3,11,16</a>]. Other common causes of AUB in adolescents include pregnancy/pregnancy-related problems, bleeding disorders (including bleeding related to systemic disease), polycystic ovary syndrome, thyroid dysfunction, hypothalamic dysfunction (eg, related to stress, exercise, underweight, acute weight loss, or obesity), hormonal or intrauterine contraception, and infection  (<a class="graphic graphic_table graphicRef62751" href="/z/d/graphic/62751.html" rel="external">table 1</a>). More than one cause may contribute or exacerbate AUB in a given adolescent.</p><p>The underlying cause of AUB determines the treatment, which ranges from observation (eg, for mild anovulatory uterine bleeding) to pharmacologic (for moderate or severe anovulatory uterine bleeding) and/or surgical therapy (eg, for leiomyoma). (See  <a class="medical medical_review" href="/z/d/html/117.html" rel="external">"Abnormal uterine bleeding in adolescents: Management"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">INITIAL EVALUATION</span></p><p class="headingAnchor" id="H740303340"><span class="h2">Triage</span><span class="headingEndMark"> — </span>Initial triage of the adolescent with suspected AUB includes assessment of hemodynamic stability and pregnancy status, which influence disposition, differential diagnosis, and further evaluation.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are hemodynamically unstable (eg, tachycardic, hypotensive, orthostatic) should be referred/transported to the emergency department for stabilization and hospitalization before proceeding with additional evaluation.</p><p></p><p class="bulletIndent1">Blood should be obtained for cross-matching in the event transfusion is necessary. Blood for evaluation of bleeding disorders should be obtained before administration of blood products or estrogen. (See <a class="local">'Bleeding disorders'</a> below and  <a class="medical medical_review" href="/z/d/html/117.html" rel="external">"Abnormal uterine bleeding in adolescents: Management", section on 'Additional evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are hemodynamically stable can be further evaluated in the outpatient setting.</p><p></p><p>It is essential to obtain a urine pregnancy test in adolescents who present with unexplained vaginal bleeding, regardless of the stated sexual history; adolescents may be unwilling to disclose sexual activity for a variety of reasons. Pregnancy and pregnancy-related problems are a common cause of uterine bleeding in adolescents and may be life-threatening.</p><p class="bulletIndent1"><span class="glyph">●</span>If the urine pregnancy test is positive, the etiology of the bleeding should be evaluated with serum beta-hCG and/or ultrasonography. Vaginal bleeding with pregnancy may be a result of:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early pregnancy loss or second trimester pregnancy loss (see  <a class="medical medical_review" href="/z/d/html/5439.html" rel="external">"Pregnancy loss (miscarriage): Terminology, risk factors, and etiology"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ectopic pregnancy (see  <a class="medical medical_review" href="/z/d/html/5487.html" rel="external">"Ectopic pregnancy: Clinical manifestations and diagnosis", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Molar pregnancy (see  <a class="medical medical_review" href="/z/d/html/3243.html" rel="external">"Hydatidiform mole: Epidemiology, clinical features, and diagnosis", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent1">Additional causes of vaginal bleeding in pregnant patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6799.html" rel="external">"Evaluation and differential diagnosis of vaginal bleeding before 20 weeks of gestation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the urine pregnancy test is negative, the patient is evaluated for nonpregnancy-related causes of AUB.</p><p></p><p class="headingAnchor" id="H7"><span class="h2">History</span><span class="headingEndMark"> — </span>The history  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) should be obtained both with and without the patient's caregiver. The caregiver may be more precise about menstrual patterns and may share details that the patient would omit. In addition, adolescents may be more comfortable discussing menstruation if a caregiver is present. Speaking with the patient alone maintains their confidentiality on subjects that they may be uncomfortable discussing in front of their caregiver (eg, sexual activity). (See  <a class="medical medical_review" href="/z/d/html/106.html" rel="external">"Confidentiality in adolescent health care", section on 'Overview'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Menstrual history</strong> – It is important to obtain as much information as possible about the menstrual history, including age of menarche, menstrual pattern, associated symptoms, and events that coincided with a change in the menstrual pattern (if there has been a change)  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1">We ask patients with irregular cycles to maintain a menstrual calendar, either on paper  (<a class="graphic graphic_figure graphicRef76376" href="/z/d/graphic/76376.html" rel="external">figure 3</a>) or using a one of several freely available smart phone "apps" [<a href="#rid17">17</a>]. We encourage all patients to track their periods [<a href="#rid2">2</a>] so they can prepare for the onset of menstrual symptoms and bleeding.</p><p></p><p class="bulletIndent1">Heavy menstrual bleeding is defined clinically as bleeding that interferes with activities and/or physical, emotional, social, and/or material quality of life [<a href="#rid1">1,13</a>]. Although it is important to try to quantify the volume of menstrual blood flow in females who report heavy menstrual flow, neither patients nor clinicians can accurately estimate the volume of blood loss [<a href="#rid18">18,19</a>]. The large variety of menstrual products on the market makes quantification challenging at best. In addition, there is little correlation between the number of pads or tampons used and actual menstrual blood loss [<a href="#rid20">20</a>]. In adolescents, hygiene preferences and school limitations can affect the quantity of sanitary products used. Nonetheless, the history should include the type/size of pad or tampon used, the number of pads or tampons used per day (or the hours each item is worn [<a href="#rid21">21</a>]), and an estimate of the degree to which the pad or tampon is soaked [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1">The pictorial blood loss assessment chart (PBAC) score is a semi-quantitative tool for measuring menstrual bleeding  (<a class="graphic graphic_figure graphicRef118961" href="/z/d/graphic/118961.html" rel="external">figure 4</a>). The PBAC score is calculated from the number of pads or tampons used, the degree to which each is saturated, and the passage of blood clots [<a href="#rid23">23</a>]. A score of ≥100 has been correlated with heavy menstrual bleeding [<a href="#rid23">23,24</a>]. In an observational study, PBAC scores correlated with adolescents' self-report of "heavy," "medium" (normal), and "light" menstrual flow; additional studies are necessary to confirm the findings and determine the appropriate cutoff value for adolescents [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1">In the absence of other means to measure blood loss, the clinician must rely upon indirect indicators of heavy flow, such as passing blood clots larger than 2.5 cm (1 inch) in diameter, bleeding through clothes, the need to change sanitary protection during the night, signs or symptoms of volume depletion during the menstrual period, and measurement of hemoglobin or hematocrit  (<a class="graphic graphic_table graphicRef69390" href="/z/d/graphic/69390.html" rel="external">table 3</a>) [<a href="#rid26">26-28</a>]. (See <a class="local">'Laboratory evaluation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sexual history</strong> – The sexual history should be obtained without the caregiver present. History should include information regarding contraception and condom use; number of partners; new partners; history of sexually transmitted infections (STIs) or current symptoms (eg, vaginal discharge, pelvic pain, bleeding with intercourse); previous pregnancy or abortion; whether sexual activity was forced or consensual; and whether the adolescent has a history of sexual abuse or assault  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) [<a href="#rid3">3,9,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">"Screening for sexually transmitted infections", section on 'Sexual history'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Past medical history</strong> – The past medical history should include information about  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) [<a href="#rid3">3,11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systemic illness, including hematologic or renal disease, gastrointestinal bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cervical polyps</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Current or recent medications (including over-the-counter medications and complementary/alternative agents); ask specifically about:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Contraceptive use and method (some forms may cause irregular bleeding)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Nonsteroidal anti-inflammatory drugs, including <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">aspirin</a>, and aspirin-containing over-the-counter medications (anticoagulation effects); antiplatelet medications can precipitate bleeding that may not have occurred otherwise in patients with von Willebrand disease (see  <a class="medical medical_review" href="/z/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms", section on 'Medications'</a> and  <a class="medical medical_review" href="/z/d/html/1307.html" rel="external">"Clinical presentation and diagnosis of von Willebrand disease", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="12873" href="/z/d/drug information/12873.html" rel="external">Valproic acid</a> (anticoagulation effects)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Antidepressants and antipsychotics (may affect the hypothalamic-pituitary-ovarian axis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Review of systems</strong> – The review of systems should include information about weight change (loss or gain), fatigue, self-induced vomiting as a means of weight control, disordered eating behaviors, hirsutism, acne, visual changes, headaches, galactorrhea, change in bowel habits, and abdominal pain  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) [<a href="#rid30">30</a>]. Unexplained weight changes, palpitations, heat or cold intolerance, and/or changes in hair, skin, or nails may indicate thyroid dysfunction or malnutrition [<a href="#rid3">3</a>]. Bleeding that occurs solely with urination or defecation suggests a urinary or gastrointestinal source.</p><p></p><p class="bulletIndent1">Adolescent females with complaints of heavy menstrual flow should be asked about bleeding from other sites (easy bruising, epistaxis, gingival bleeding, postoperative bleeding) and symptoms of acute or chronic anemia (lightheadedness, fatigue, syncope, weakness, headache) [<a href="#rid3">3,9,11,31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Social history</strong> – The social history should include information about social stressors, substance use, exercise patterns/athletic participation (eg, intensity of exercise and training). Asking questions about school absence or decreased participation in recreational activities (eg, sports, hobbies) related to menses may provide information about effects on quality of life [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – The family history should include information about bleeding disorders, infertility, menstrual disorders, thyroid disease, and leukemia or other types of cancer [<a href="#rid3">3,32,33</a>]. A strong family history of diabetes mellitus and or disorders of lipids or triglycerides may be suggestive of polycystic ovary syndrome (PCOS). (See  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents"</a>.)</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Information from the physical examination may help to narrow the diagnostic possibilities and target subsequent laboratory or radiographic evaluation  (<a class="graphic graphic_table graphicRef66045" href="/z/d/graphic/66045.html" rel="external">table 4</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>General examination</strong> – The general examination should include  (<a class="graphic graphic_table graphicRef66045" href="/z/d/graphic/66045.html" rel="external">table 4</a>) [<a href="#rid3">3,11,32</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Measurement of height, weight, and arm span.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Visual assessment of body habitus and fat distribution (eg, Cushing syndrome, Turner syndrome).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vital signs, including orthostatic vital signs.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Palpation of the thyroid gland for enlargement or other abnormalities.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Signs of androgen excess (eg, hirsutism, acne, male-pattern balding) to evaluate for PCOS. (See  <a class="medical medical_review" href="/z/d/html/94182.html" rel="external">"Diagnostic evaluation of polycystic ovary syndrome in adolescents", section on 'History and physical examination'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evidence of easy bruising or oozing gums to evaluate for a bleeding disorder.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Examination of the optic fundi and visual field testing to evaluate the possibility of a pituitary tumor.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of lymph nodes (lymphadenopathy may be a sign of malignancy).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sexual maturity rating of the breasts  (<a class="graphic graphic_picture graphicRef72038" href="/z/d/graphic/72038.html" rel="external">picture 1</a>) and assessment for galactorrhea. Breast development provides evidence of estrogenization.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Examination of the hair and skin for thinning hair, dry skin, excessive sweating, acanthosis nigricans, or signs of abnormal bleeding (eg, petechiae and/or bruising) should be noted, particularly in patients with heavy menstrual bleeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Palpation of the abdomen (pregnancy, uterine mass, ovarian mass).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>External genitalia</strong> – Examination of external genitalia includes evaluation of clitoral size, sexual maturity rating for pubic hair development  (<a class="graphic graphic_picture graphicRef79782" href="/z/d/graphic/79782.html" rel="external">picture 2</a>), and the hymen  (<a class="graphic graphic_figure graphicRef57977" href="/z/d/graphic/57977.html" rel="external">figure 5</a>).</p><p></p><p class="bulletIndent1">It is also important to look for extrauterine sources of bleeding (eg, perineal trauma, vulvar lesions, signs of STIs). Adolescent females who have signs of perineal trauma should be questioned privately about sexual abuse or assault. (See  <a class="medical medical_review" href="/z/d/html/115.html" rel="external">"Sexually transmitted infections: Issues specific to adolescents", section on 'STI clinical patterns'</a> and  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pelvic examination</strong> – Pelvic examination may be distressing for adolescent females, especially those who are not sexually active. Unless the bleeding is severe, the pelvic and rectal examination may be postponed pending a trial of medical therapy, if such therapy is warranted. As an alternative, pelvic ultrasonography can provide relevant information about genital tract anatomy. (See  <a class="medical medical_review" href="/z/d/html/117.html" rel="external">"Abnormal uterine bleeding in adolescents: Management"</a> and  <a class="medical medical_review" href="/z/d/html/5417.html" rel="external">"Congenital anomalies of the hymen and vagina"</a>.)</p><p></p><p class="bulletIndent1">When warranted, many adolescents can tolerate a one finger digital examination (provided the hymenal opening is wide enough to admit the finger [<a href="#rid34">34</a>]) to assess the depth of the vagina and the presence and normality of the cervix, uterus, and ovaries. A rectoabdominal examination may be helpful if the digital examination is uncomfortable or not possible.</p><p></p><p class="bulletIndent1">Many adolescents also can tolerate a speculum examination with an appropriate size speculum to look for abnormalities (eg, polyps, vaginal lacerations).</p><p></p><p class="bulletIndent1">Pelvic examination under anesthesia may be necessary if pelvic examination is inadequate or an appropriate diagnosis cannot be established despite imaging.</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Pelvic ultrasonography</span><span class="headingEndMark"> — </span>Pelvic ultrasonography via the abdomen is another method of evaluating pelvic anatomy (ie, vagina, uterus, ovaries) in adolescents when clinicians prefer to avoid digital and/or speculum examination or when digital and/or speculum examinations are limited. Pelvic ultrasonography can also evaluate structural abnormalities (ie, vaginal or cervical outlet obstruction in patients with cyclic pain, fibroids, polyps, or ovarian masses).</p><p>Relevant findings on pelvic ultrasonography may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Vaginal or cervical outlet obstruction in patients with cyclic pain (see  <a class="medical medical_review" href="/z/d/html/5417.html" rel="external">"Congenital anomalies of the hymen and vagina"</a> and  <a class="medical medical_review" href="/z/d/html/5428.html" rel="external">"Benign cervical lesions and congenital anomalies of the cervix"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Leiomyomas (fibroids) (see  <a class="medical medical_review" href="/z/d/html/5486.html" rel="external">"Uterine fibroids (leiomyomas): Epidemiology, clinical features, diagnosis, and natural history", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ovarian mass (see  <a class="medical medical_review" href="/z/d/html/5909.html" rel="external">"Ovarian cysts in infants, children, and adolescents"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple follicles around the periphery of the ovary (may indicate PCOS) (see  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents", section on 'Differential diagnosis'</a>)</p><p></p><p class="headingAnchor" id="H13"><span class="h2">Laboratory evaluation</span><span class="headingEndMark"> — </span>Our initial evaluation for adolescents who present with AUB generally includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy test (if not already performed)</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobin or hematocrit with a platelet count</p><p class="bulletIndent1"><span class="glyph">●</span>Measurement of thyroid-stimulating hormone (TSH)</p><p class="bulletIndent1"><span class="glyph">●</span>Screening for STIs if sexually active (see  <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">"Screening for sexually transmitted infections", section on 'Females'</a>)</p><p></p><p>Prolactin measurement may also be warranted, particularly in females with headaches or nipple/breast complaints (eg, galactorrhea). (See  <a class="medical medical_review" href="/z/d/html/6638.html" rel="external">"Clinical manifestations and evaluation of hyperprolactinemia", section on 'Clinical presentation'</a>.)</p><p>Additional laboratory evaluation for adolescents with AUB depends upon the pattern of bleeding and findings from the history and examination. (See <a class="local">'Causes of amenorrhea'</a> below and <a class="local">'Causes of irregular bleeding'</a> below and <a class="local">'Causes of heavy menstrual bleeding'</a> below and <a class="local">'Causes of intermenstrual bleeding'</a> below.)</p><p class="headingAnchor" id="H2142220279"><span class="h1">APPROACH TO DIAGNOSIS</span></p><p class="headingAnchor" id="H2978932171"><span class="h2">Classify the bleeding pattern</span><span class="headingEndMark"> — </span>Information from the initial evaluation is used to classify abnormal genital bleeding into one of the following patterns  (<a class="graphic graphic_table graphicRef108700" href="/z/d/graphic/108700.html" rel="external">table 5</a>) [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Amenorrhea (absence of menses)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Irregular bleeding (unpredictable intervals between episodes of menstrual bleeding)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged and/or heavy menstrual bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged menstrual bleeding lasts &gt;7 days.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heavy menstrual bleeding is defined clinically as soaking a pad or tampon more than every two hours  (<a class="graphic graphic_figure graphicRef118961" href="/z/d/graphic/118961.html" rel="external">figure 4</a>) or interfering with activities and/or quality of life (physical, emotional, social, and/or material) [<a href="#rid1">1,13</a>]. (See <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intermenstrual bleeding (bleeding between well-defined cyclical menses)  (<a class="graphic graphic_figure graphicRef109660" href="/z/d/graphic/109660.html" rel="external">figure 6</a>)</p><p></p><p class="bulletIndent1">Although this categorization narrows the differential diagnosis and determines the need for additional testing  (<a class="graphic graphic_table graphicRef108700" href="/z/d/graphic/108700.html" rel="external">table 5</a>), it may be difficult to classify the abnormal menstrual bleeding into a particular pattern for a number of reasons. Menstrual cycles can vary substantially in the first year or two after menarche. The distinction between regular and irregular cycles is not always clear. The categories may overlap (eg, irregular bleeding can also be heavy). Causative conditions may have more than one pattern or present atypically.</p><p></p><p class="headingAnchor" id="H1415891180"><span class="h2">Causes of amenorrhea</span><span class="headingEndMark"> — </span>Amenorrhea is the absence of menses. Amenorrhea may be primary (absence of menarche by age 15 years) or secondary (absence of menses for ≥90 days in females who previously had regular menstrual cycles or &gt;6 months in those who had irregular menses). Pregnancy is the most common cause of amenorrhea in reproductive-age females. (See  <a class="medical medical_review" href="/z/d/html/110.html" rel="external">"Pregnancy in adolescents", section on 'Diagnosis of pregnancy'</a>.)</p><p>Other causes of amenorrhea and the evaluation and management of primary and secondary amenorrhea are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/104218.html" rel="external">"Causes of primary amenorrhea"</a> and  <a class="medical medical_review" href="/z/d/html/7403.html" rel="external">"Evaluation and management of primary amenorrhea"</a> and  <a class="medical medical_review" href="/z/d/html/104135.html" rel="external">"Epidemiology and causes of secondary amenorrhea"</a> and  <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">"Evaluation and management of secondary amenorrhea"</a>.)</p><p class="headingAnchor" id="H2361843612"><span class="h2">Causes of irregular bleeding</span><span class="headingEndMark"> — </span>Irregular bleeding refers to unpredictable intervals between episodes of menstrual bleeding. Irregular bleeding also may be prolonged and/or heavy.</p><p class="headingAnchor" id="H4123850366"><span class="h3">Anovulatory uterine bleeding</span><span class="headingEndMark"> — </span>During the first one to two years after menarche, the most common cause of irregular bleeding in nonpregnant adolescents is anovulatory uterine bleeding due to an immature hypothalamic-pituitary-ovarian axis [<a href="#rid3">3,16,35</a>]. (See <a class="local">'Establishing ovulatory cycles'</a> above.)</p><p>Clinical features suggestive of anovulatory uterine bleeding include irregular periods and the absence of premenstrual symptoms (eg, breast tenderness, bloating, mood swings, or uterine cramping). The irregular bleeding pattern commonly is characterized by phases of two or more months without bleeding followed by phases with spotting, heavy bleeding, or sudden and substantial hemorrhage [<a href="#rid9">9</a>].</p><p>Although laboratory evaluation is not necessary to diagnose anovulation or immaturity of the hypothalamic-pituitary-ovarian axis in a patient with a typical clinical presentation, before attributing AUB to immaturity of the hypothalamic-pituitary-ovarian axis, other causes of ovulatory dysfunction in adolescents  (<a class="graphic graphic_table graphicRef62751" href="/z/d/graphic/62751.html" rel="external">table 1</a>) must be considered and excluded.</p><p>The need for laboratory evaluation for other causes of anovulatory bleeding is determined by the findings in the history  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) and examination  (<a class="graphic graphic_table graphicRef66045" href="/z/d/graphic/66045.html" rel="external">table 4</a>). In addition to the initial laboratory evaluation described above (see <a class="local">'Laboratory evaluation'</a> above), evaluation for other conditions of ovulatory dysfunction may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Follicle-stimulating hormone (FSH) to evaluate the hypothalamic-pituitary-ovarian axis</p><p></p><p class="bulletIndent1">An elevated FSH suggests ovarian insufficiency. When possible, we try to obtain FSH on day 3 of the menstrual cycle (by convention, the first day of menses is day 1 of the cycle, even in females with irregular cycles). Although the concentrations of FSH vary throughout the cycle  (<a class="graphic graphic_figure graphicRef62189" href="/z/d/graphic/62189.html" rel="external">figure 1</a>), they are most reproducible on day 3, when they are at their lowest concentrations. If day 3 is not reproducible because of the pattern of bleeding, FSH may be obtained at any time during the cycle. However, the concentration may not be at its nadir and repeat testing may be necessary to assess the accuracy of the result.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid-stimulating hormone (TSH) to screen for hypothyroidism and hyperthyroidism, if not already performed (see  <a class="medical medical_review" href="/z/d/html/5838.html" rel="external">"Acquired hypothyroidism in childhood and adolescence", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">"Clinical manifestations and diagnosis of Graves disease in children and adolescents", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolactin to assess for hyperprolactinemia (see  <a class="medical medical_review" href="/z/d/html/6626.html" rel="external">"Causes of hyperprolactinemia"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Testosterone and additional evaluation for polycystic ovary syndrome (PCOS) in females with signs of hyperandrogenism (hirsutism, acne, male pattern balding) (see  <a class="medical medical_review" href="/z/d/html/94182.html" rel="external">"Diagnostic evaluation of polycystic ovary syndrome in adolescents"</a>)</p><p></p><p class="bulletIndent1">Additional evaluation for hirsutism is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism", section on 'Biochemical testing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pelvic ultrasonography to look for ovarian pathology</p><p></p><p>If pathologic causes are ruled out, and the patient is not bothered by irregular menses, anovulatory bleeding may be managed expectantly for the first few years after menarche. Long-term monitoring of females with anovulatory uterine bleeding is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/117.html" rel="external">"Abnormal uterine bleeding in adolescents: Management", section on 'Long-term monitoring'</a>.)</p><p class="headingAnchor" id="H1015045337"><span class="h3">Polycystic ovary syndrome</span><span class="headingEndMark"> — </span>PCOS is another common cause of irregular bleeding in adolescents, though it also can be associated with other patterns of bleeding (eg, amenorrhea, infrequent bleeding, heavy bleeding) [<a href="#rid3">3,11</a>].</p><p>Clinical features of PCOS include physical signs of hyperandrogenism (hirsutism, acne, clitoromegaly) or laboratory signs of hyperandrogenism (elevated testosterone) in conjunction with menstrual irregularities and/or insulin resistance (eg, acanthosis nigricans) [<a href="#rid36">36</a>]. Any of these findings may be the sole presenting feature of PCOS, but one feature is not sufficient to establish the diagnosis  (<a class="graphic graphic_table graphicRef107842" href="/z/d/graphic/107842.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents"</a>.)</p><p>The diagnosis of PCOS is based upon clinical and biochemical criteria. Other causes of hyperandrogenism and irregular menses must be excluded. The differential diagnosis and diagnostic evaluation of PCOS are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents", section on 'Differential diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/94182.html" rel="external">"Diagnostic evaluation of polycystic ovary syndrome in adolescents"</a>.)</p><p class="headingAnchor" id="H171002525"><span class="h3">Other causes</span><span class="headingEndMark"> — </span>Other hormonal causes of irregular bleeding in adolescents include [<a href="#rid37">37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypothyroidism (may cause heavy menstrual bleeding as well as irregular bleeding) (see <a class="local">'Causes of heavy menstrual bleeding'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperprolactinemia – Causes of hyperprolactinemia include pituitary tumors and certain medications  (<a class="graphic graphic_table graphicRef75914" href="/z/d/graphic/75914.html" rel="external">table 7</a>) (may cause amenorrhea as well as irregular/less bleeding) (see  <a class="medical medical_review" href="/z/d/html/6626.html" rel="external">"Causes of hyperprolactinemia"</a> and  <a class="medical medical_review" href="/z/d/html/6638.html" rel="external">"Clinical manifestations and evaluation of hyperprolactinemia", section on 'Menstrual cycle dysfunction'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypothalamic dysfunction related to exercise, psychological stress, being underweight, acute weight loss, or obesity (may cause amenorrhea as well as irregular/less bleeding) (see  <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">"Evaluation and management of secondary amenorrhea"</a>)</p><p></p><p>Infections of the vulva, vagina, or cervix may cause intermenstrual bleeding that appears to be irregular. (See <a class="local">'Causes of intermenstrual bleeding'</a> below.)</p><p class="headingAnchor" id="H2710291910"><span class="h2">Causes of heavy menstrual bleeding</span><span class="headingEndMark"> — </span>In adolescents, heavy menstrual bleeding typically occurs at irregular intervals, indicating that it is anovulatory. (See <a class="local">'Anovulatory uterine bleeding'</a> above.)</p><p>Heavy menstrual bleeding that occurs at regular intervals or at the onset of menses often is related to a bleeding disorder [<a href="#rid38">38-42</a>]. Less commonly, heavy menstrual bleeding may be caused by systemic illness or structural lesions [<a href="#rid39">39,43</a>].</p><p class="headingAnchor" id="H928693211"><span class="h3">Bleeding disorders</span><span class="headingEndMark"> — </span>We consider the possibility of a bleeding disorder (coagulation factor deficiency or inherited or acquired platelet disorder) in adolescents who present with first menses with extremely heavy flow, bleeding requiring blood transfusion or hospitalization, and patients with refractory heavy menstrual bleeding and concomitant anemia. In such patients, consultation with a hematologist is warranted [<a href="#rid44">44,45</a>].</p><p>In retrospective studies in adolescents hospitalized for heavy menstrual bleeding, the prevalence of bleeding disorders ranges from 5 to 28 percent [<a href="#rid39">39-41,43,46</a>]. In a series of 59 patients who were hospitalized with acute heavy menstrual bleeding and in whom genital tract pathology had been excluded, an underlying coagulopathy was identified in approximately 20 percent overall, 33 percent of those requiring transfusion, and 50 percent of those presenting at menarche [<a href="#rid46">46</a>]. </p><p>In observational studies in adolescents who were evaluated in a hematology or multidisciplinary clinic for heavy menstrual bleeding, the prevalence of bleeding disorders ranges approximately 20 to 60 percent [<a href="#rid42">42,47-51</a>].</p><p>Bleeding disorders among adolescents with heavy menstrual bleeding include, but are not limited to [<a href="#rid37">37-40,42,46,47,50</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>von Willebrand disease (see  <a class="medical medical_review" href="/z/d/html/1307.html" rel="external">"Clinical presentation and diagnosis of von Willebrand disease"</a> and  <a class="medical medical_review" href="/z/d/html/139017.html" rel="external">"von Willebrand disease (VWD): Gynecologic and obstetric considerations"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Factor VII deficiency (see  <a class="medical medical_review" href="/z/d/html/1336.html" rel="external">"Rare inherited coagulation disorders"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune thrombocytopenia (see  <a class="medical medical_review" href="/z/d/html/5930.html" rel="external">"Immune thrombocytopenia (ITP) in children: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Platelet dysfunction (see  <a class="medical medical_review" href="/z/d/html/6675.html" rel="external">"Inherited platelet function disorders (IPFDs)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia secondary to malignancy or treatment for malignancy (ie, chemotherapy or hematopoietic stem cell transplantation) (see  <a class="medical medical_review" href="/z/d/html/5921.html" rel="external">"Causes of thrombocytopenia in children"</a>)</p><p></p><p>Among these, von Willebrand disease is most common; in a systematic review of 11 studies including 988 adult females presenting with heavy menstrual bleeding (not limited to adolescents), the prevalence of von Willebrand disease was 13 percent [<a href="#rid52">52</a>].</p><p>The <strong>minimum</strong> laboratory evaluation for bleeding disorder in adolescents with heavy menstrual bleeding should include (see  <a class="medical medical_review" href="/z/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms", section on 'Initial laboratory evaluation'</a>) [<a href="#rid12">12,44,53</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count with platelets and examination of the peripheral blood smear and ferritin to detect anemia, iron deficiency without anemia [<a href="#rid54">54</a>], or thrombocytopenia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coagulation panel (activated partial thromboplastin time [aPTT]/partial thromboplastin time [PTT], prothrombin time [PT], and fibrinogen)</p><p></p><p>The evaluation generally also includes a von Willebrand panel [<a href="#rid3">3,53,55,56</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Plasma von Willebrand factor (VWF) antigen</p><p class="bulletIndent1"><span class="glyph">●</span>Plasma VWF activity (ristocetin cofactor activity)</p><p class="bulletIndent1"><span class="glyph">●</span>Factor VIII activity</p><p></p><p>The von Willebrand panel should be obtained at the time of presentation or after exogenous estrogen has been discontinued for seven days. Exogenous estrogen may elevate VWF into the normal range [<a href="#rid57">57</a>].</p><p>Consultation with a hematologist is suggested if any abnormalities are detected on the von Willebrand panel. (See  <a class="medical medical_review" href="/z/d/html/1307.html" rel="external">"Clinical presentation and diagnosis of von Willebrand disease"</a>.)</p><p class="headingAnchor" id="H1188571520"><span class="h3">Other causes</span><span class="headingEndMark"> — </span>Less common causes of heavy menstrual bleeding in adolescents include:</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic illness that affects ovarian or liver function, causing abnormalities in ovulation (eg, diabetes mellitus) or coagulation (eg, systemic lupus erythematosus, renal failure, malignancy, myelodysplasia)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other endocrine disorders (eg, hypothyroidism, hyperthyroidism) may cause heavy menstrual bleeding as well as irregular bleeding</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Structural lesions (eg, polyps, uterine leiomyomas [fibroids])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medications (eg, anticoagulants, platelet inhibitors, nonsteroidal anti-inflammatory drugs including <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">aspirin</a>)</p><p></p><p>In adolescents with heavy menstrual bleeding in whom a bleeding disorder has been excluded, additional laboratory evaluation may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Measurement of serum TSH to evaluate thyroid function (if not already performed)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for chronic disease, systemic disease, or medication-related bleeding as warranted by the history  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>) and physical examination  (<a class="graphic graphic_table graphicRef66045" href="/z/d/graphic/66045.html" rel="external">table 4</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pelvic ultrasonography (if it has not already been performed) to assess structural causes, such as leiomyomas (fibroids), polyps, and/or ovarian tumors (see <a class="local">'Pelvic ultrasonography'</a> above)</p><p></p><p class="headingAnchor" id="H2663180232"><span class="h2">Causes of intermenstrual bleeding</span></p><p class="headingAnchor" id="H682634398"><span class="h3">Hormonal contraception and intrauterine devices</span><span class="headingEndMark"> — </span>Intermenstrual bleeding is a common side effect of oral contraceptives, depot <a class="drug drug_pediatric" data-topicid="12577" href="/z/d/drug information/12577.html" rel="external">medroxyprogesterone acetate</a>, the contraceptive patch, the vaginal ring, the contraceptive implant, and intrauterine devices. Intermenstrual bleeding also may occur if hormonal contraception is not administered as prescribed. (See  <a class="medical medical_review" href="/z/d/html/5474.html" rel="external">"Evaluation and management of unscheduled bleeding in individuals using hormonal contraception"</a> and  <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">"Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Unscheduled bleeding'</a>.)</p><p>Before attributing intermenstrual bleeding to contraception, the possibility of pregnancy, cervicitis, or endometrial/cervical pathology must be considered and excluded by examination and/or appropriate laboratory tests.</p><p class="headingAnchor" id="H1324927028"><span class="h3">Infection</span><span class="headingEndMark"> — </span>Sexually transmitted infections (STI) may cause intermenstrual bleeding in sexually active adolescents and/or those who have been sexually abused or assaulted. Such patients who have acute vaginal bleeding unrelated to menses should be assessed for cervicitis and upper genital tract infection. The prevalence of <em>Chlamydia trachomatis</em> in females with AUB is underestimated [<a href="#rid58">58</a>]. Routine screening for STI is recommended for sexually active adolescents with menstrual abnormalities. (See  <a class="medical medical_review" href="/z/d/html/115.html" rel="external">"Sexually transmitted infections: Issues specific to adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/7581.html" rel="external">"Pelvic inflammatory disease: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H3319125567"><span class="h3">Other causes</span><span class="headingEndMark"> — </span>Extrauterine gynecologic causes of intermittent bleeding that may mimic intermenstrual uterine bleeding include:</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical polyps (see  <a class="medical medical_review" href="/z/d/html/5428.html" rel="external">"Benign cervical lesions and congenital anomalies of the cervix", section on 'Polyps'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cervical ectropion (eversion of the endocervix) (see  <a class="medical medical_review" href="/z/d/html/5428.html" rel="external">"Benign cervical lesions and congenital anomalies of the cervix", section on 'Ectropion'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Foreign bodies (retained tampons are most common among adolescents)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trauma (see  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/2765.html" rel="external">"Evaluation and management of adult and adolescent sexual assault victims in the emergency department"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Certain medications (eg, anticoagulants, <a class="drug drug_pediatric" data-topicid="12873" href="/z/d/drug information/12873.html" rel="external">valproic acid</a>)</p><p></p><p>Less common causes of nonuterine genital tract bleeding in adolescents are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5440.html" rel="external">"Causes of female genital tract bleeding"</a>.)</p><p class="headingAnchor" id="H2425747507"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15427.html" rel="external">"Patient education: Absent or irregular periods (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/15420.html" rel="external">"Patient education: Heavy periods (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/2184.html" rel="external">"Patient education: Absent or irregular periods (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/8401.html" rel="external">"Patient education: Abnormal uterine bleeding (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/8405.html" rel="external">"Patient education: Heavy or prolonged menstrual bleeding (menorrhagia) (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2725548425"><span class="h1">PATIENT PERSPECTIVE TOPIC</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/z/d/html/141288.html" rel="external">"Patient perspective: von Willebrand disease"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Abnormal uterine bleeding (AUB) refers to menstrual bleeding that occurs outside the normal range and includes absence of menses, menses at irregular intervals, heavy menstrual flow, and intermenstrual bleeding. "Anovulatory uterine bleeding" is the preferred term for heavy noncyclic uterine bleeding unrelated to structural lesions of the uterus or systemic disease, the most common cause of AUB in adolescents. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes</strong> – Adolescents with AUB typically present with a complaint of abnormal "vaginal bleeding." The uterus is the most likely source of vaginal bleeding  (<a class="graphic graphic_table graphicRef62751" href="/z/d/graphic/62751.html" rel="external">table 1</a>). Anovulatory uterine bleeding related to immaturity of the hypothalamic-pituitary-ovarian axis is the most common cause of AUB in nonpregnant adolescents in the first year or two after menarche. (See <a class="local">'Causes of vaginal bleeding in adolescents'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Triage</strong> – Initial triage of the adolescent with suspected abnormal uterine bleeding includes assessment of hemodynamic stability and pregnancy status. (See <a class="local">'Triage'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who are hemodynamically unstable (eg, tachycardic, hypotensive, orthostatic) should be referred/transported to the emergency department for stabilization and hospitalization before proceeding with additional evaluation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Urine pregnancy test is essential, regardless of the stated sexual history. Pregnancy and pregnancy-related problems commonly cause uterine bleeding in adolescents and may be life-threatening (eg, ectopic pregnancy, pregnancy loss). (See  <a class="medical medical_review" href="/z/d/html/6799.html" rel="external">"Evaluation and differential diagnosis of vaginal bleeding before 20 weeks of gestation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to diagnosis </strong>– In the nonpregnant adolescent with AUB, the history  (<a class="graphic graphic_table graphicRef70444" href="/z/d/graphic/70444.html" rel="external">table 2</a>), examination  (<a class="graphic graphic_table graphicRef66045" href="/z/d/graphic/66045.html" rel="external">table 4</a>), and initial laboratory evaluation focus on clinical features associated with specific causes and identification of the predominant bleeding pattern, which determines additional evaluation  (<a class="graphic graphic_table graphicRef108700" href="/z/d/graphic/108700.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Amenorrhea – Pregnancy is the most common cause of amenorrhea in reproductive-age females. The approach to amenorrhea is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7403.html" rel="external">"Evaluation and management of primary amenorrhea"</a> and  <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">"Evaluation and management of secondary amenorrhea"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular bleeding – Immaturity of the hypothalamic-pituitary-ovarian axis with anovulatory cycles is the most common cause of irregular bleeding in nonpregnant adolescents during the first one to two years after menarche. Other causes include polycystic ovary syndrome, hyperprolactinemia, and hypothalamic dysfunction related to exercise, stress, or changes in body weight. (See <a class="local">'Causes of irregular bleeding'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged and/or heavy menstrual bleeding – Bleeding disorders (eg, von Willebrand disease) are a common cause of prolonged and/or heavy menstrual bleeding in nonpregnant adolescents with regular menses. Bleeding disorders also should be considered in adolescents with AUB who present with first menses with extremely heavy flow, bleeding requiring blood transfusion, and refractory heavy menstrual bleeding with concomitant anemia. (See <a class="local">'Bleeding disorders'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intermenstrual bleeding – Causes of intermenstrual bleeding in adolescents include use of hormonal contraception or intrauterine devices, sexually transmitted infections, and extrauterine causes of intermittent bleeding that mimic intermenstrual uterine bleeding. (See <a class="local">'Causes of intermenstrual bleeding'</a> above.)</p><p></p><p class="headingAnchor" id="H101961693"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate, Inc. acknowledge Dr. Robert Zurawin, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 2018; 143:393.</a></li><li><a class="nounderline abstract_t">ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol 2015; 126:e143. Reaffirmed 2021</a></li><li><a class="nounderline abstract_t">Hernandez A, Dietrich JE. Abnormal Uterine Bleeding in the Adolescent. Obstet Gynecol 2020; 135:615.</a></li><li><a class="nounderline abstract_t">Flug D, Largo RH, Prader A. Menstrual patterns in adolescent Swiss girls: a longitudinal study. Ann Hum Biol 1984; 11:495.</a></li><li><a class="nounderline abstract_t">Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12:77.</a></li><li><a class="nounderline abstract_t">Gunn HM, Tsai MC, McRae A, Steinbeck KS. Menstrual Patterns in the First Gynecological Year: A Systematic Review. J Pediatr Adolesc Gynecol 2018; 31:557.</a></li><li><a class="nounderline abstract_t">Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983; 57:82.</a></li><li><a class="nounderline abstract_t">Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984; 20:231.</a></li><li><a class="nounderline abstract_t">Mitan LA, Slap GB. Adolescent menstrual disorders. Update. Med Clin North Am 2000; 84:851.</a></li><li class="breakAll">Gray SH, French A, Emans SJ. Abnormal uterine bleeding in the adolescent. In: Emans, Laufer, Goldstein’s Pediatric &amp; Adolescent Gynecology, 7th ed, Emans SJ, Laufer MR, DiVasta AD (Eds), Wolters Kluwer, Philadelphia 2020. p.418.</li><li><a class="nounderline abstract_t">Borzutzky C, Jaffray J. Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents. JAMA Pediatr 2020; 174:186.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol 2013; 121:891. Reaffirmed 2021.</a></li><li class="breakAll">National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. March 2018. Available at: https://www.nice.org.uk/guidance/ng88 (Accessed on June 14, 2018).</li><li class="breakAll">APGO educational series on women's health issues. Clinical management of abnormal uterine bleeding. Association of Professors of Gynecology and Obstetrics, 2006.</li><li><a class="nounderline abstract_t">Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113:3.</a></li><li><a class="nounderline abstract_t">Lemarchand-Béraud T, Zufferey MM, Reymond M, Rey I. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab 1982; 54:241.</a></li><li><a class="nounderline abstract_t">Jacobson AE, Vesely SK, Haamid F, et al. Mobile Application vs Paper Pictorial Blood Assessment Chart to Track Menses in Young Women: A Randomized Cross-over Design. J Pediatr Adolesc Gynecol 2018; 31:84.</a></li><li><a class="nounderline abstract_t">Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966; 45:320.</a></li><li><a class="nounderline abstract_t">Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG 2000; 107:320.</a></li><li><a class="nounderline abstract_t">Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984; 149:788.</a></li><li><a class="nounderline abstract_t">Strickland JL, Wall JW. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 2003; 30:321.</a></li><li><a class="nounderline abstract_t">Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85:977.</a></li><li><a class="nounderline abstract_t">Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97:734.</a></li><li><a class="nounderline abstract_t">Halimeh S, Rott H, Kappert G. PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding. Haemophilia 2016; 22:e217.</a></li><li><a class="nounderline abstract_t">Sanchez J, Andrabi S, Bercaw JL, Dietrich JE. Quantifying the PBAC in a pediatric and adolescent gynecology population. Pediatr Hematol Oncol 2012; 29:479.</a></li><li><a class="nounderline abstract_t">Adams Hillard PJ, Deitch HR. Menstrual disorders in the college age female. Pediatr Clin North Am 2005; 52:179.</a></li><li><a class="nounderline abstract_t">Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004; 190:1216.</a></li><li><a class="nounderline abstract_t">Matteson KA. Menstrual questionnaires for clinical and research use. Best Pract Res Clin Obstet Gynaecol 2017; 40:44.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Gray SH. Menstrual disorders. Pediatr Rev 2013; 34:6.</a></li><li><a class="nounderline abstract_t">Kouides PA, Conard J, Peyvandi F, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005; 84:1345.</a></li><li><a class="nounderline abstract_t">Rimsza ME. Dysfunctional uterine bleeding. Pediatr Rev 2002; 23:227.</a></li><li><a class="nounderline abstract_t">Jayasinghe Y, Moore P, Donath S, et al. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol 2005; 45:439.</a></li><li><a class="nounderline abstract_t">Bravender T, Emans SJ. Menstrual disorders. Dysfunctional uterine bleeding. Pediatr Clin North Am 1999; 46:545.</a></li><li><a class="nounderline abstract_t">Deligeoroglou E, Karountzos V, Creatsas G. Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology. Gynecol Endocrinol 2013; 29:74.</a></li><li><a class="nounderline abstract_t">Pinola P, Lashen H, Bloigu A, et al. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod 2012; 27:3279.</a></li><li><a class="nounderline abstract_t">Minjarez DA. Abnormal bleeding in adolescents. Semin Reprod Med 2003; 21:363.</a></li><li><a class="nounderline abstract_t">Bevan JA, Maloney KW, Hillery CA, et al. Bleeding disorders: A common cause of menorrhagia in adolescents. J Pediatr 2001; 138:856.</a></li><li><a class="nounderline abstract_t">Smith YR, Quint EH, Hertzberg RB. Menorrhagia in adolescents requiring hospitalization. J Pediatr Adolesc Gynecol 1998; 11:13.</a></li><li><a class="nounderline abstract_t">Kanbur NO, Derman O, Kutluk T, Gürgey A. Coagulation disorders as the cause of menorrhagia in adolescents. Int J Adolesc Med Health 2004; 16:183.</a></li><li><a class="nounderline abstract_t">Oral E, Cağdaş A, Gezer A, et al. Hematological abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 2002; 266:72.</a></li><li><a class="nounderline abstract_t">Díaz R, Dietrich JE, Mahoney D Jr, et al. Hemostatic abnormalities in young females with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 2014; 27:324.</a></li><li><a class="nounderline abstract_t">Falcone T, Desjardins C, Bourque J, et al. Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994; 39:761.</a></li><li><a class="nounderline abstract_t">Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG Committee Opinion No. 785. Obstet Gynecol 2019; 134:e71. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">Zia A, Kouides P, Khodyakov D, et al. Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs. J Thromb Haemost 2020; 18:2759.</a></li><li><a class="nounderline abstract_t">Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981; 139:277.</a></li><li><a class="nounderline abstract_t">O'Brien B, Mason J, Kimble R. Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding: The Queensland Statewide Paediatric and Adolescent Gynaecology Service. J Pediatr Adolesc Gynecol 2019; 32:122.</a></li><li><a class="nounderline abstract_t">Vo KT, Grooms L, Klima J, et al. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia 2013; 19:71.</a></li><li><a class="nounderline abstract_t">Karaman K, Ceylan N, Karaman E, et al. Evaluation of the Hemostatic Disorders in Adolescent Girls with Menorrhagia: Experiences from a Tertiary Referral Hospital. Indian J Hematol Blood Transfus 2016; 32:356.</a></li><li><a class="nounderline abstract_t">Trillo A, Kronenfeld R, Simms-Cendan J, et al. High Prevalence of Congenital Factor VII (FVII) Deficiency in Adolescent Females with Heavy Menstrual Bleeding and Iron Deficiency Anemia. J Pediatr Adolesc Gynecol 2022; 35:647.</a></li><li><a class="nounderline abstract_t">Zia A, Jain S, Kouides P, et al. Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort. Haematologica 2020; 105:1969.</a></li><li><a class="nounderline abstract_t">Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111:734.</a></li><li><a class="nounderline abstract_t">Demers C, Derzko C, David M, et al. Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynaecol Obstet 2006; 95:75.</a></li><li><a class="nounderline abstract_t">Johnson S, Lang A, Sturm M, O'Brien SH. Iron Deficiency without Anemia: A Common Yet Under-Recognized Diagnosis in Young Women with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol 2016; 29:628.</a></li><li><a class="nounderline abstract_t">Mannucci PM. Treatment of von Willebrand's Disease. N Engl J Med 2004; 351:683.</a></li><li><a class="nounderline abstract_t">Sokkary NA, Venkateswaran L, Dietrich JE, Teruya J. Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis. J Pediatr Adolesc Gynecol 2012; 25:233.</a></li><li><a class="nounderline abstract_t">Committee on Adolescent Health Care, Committee on Gynecologic Practice. Committee Opinion No.580: von Willebrand disease in women. Obstet Gynecol 2013; 122:1368. Reaffirmed 2020.</a></li><li><a class="nounderline abstract_t">Toth M, Patton DL, Esquenazi B, et al. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol 2007; 57:361.</a></li></ol></div><div id="topicVersionRevision">Topic 116 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30198563" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26595586" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32028485" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Abnormal Uterine Bleeding in the Adolescent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6524865" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Menstrual patterns in adolescent Swiss girls: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5419031" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Variation of the human menstrual cycle through reproductive life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30064002" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Menstrual Patterns in the First Gynecological Year: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6222061" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6231419" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Endocrine characteristics of adolescent menstrual cycles: impact of early menarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10928192" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Adolescent menstrual disorders. Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10928192" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Adolescent menstrual disorders. Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31886837" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635706" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635706" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635706" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21345435" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6798063" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29030160" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mobile Application vs Paper Pictorial Blood Assessment Chart to Track Menses in Young Women: A Randomized Cross-over Design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5922481" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Menstrual blood loss--a population study. Variation at different ages and attempts to define normality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10740326" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Assessment of menstrual blood loss using a pictorial chart: a validation study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6380294" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A preliminary study of factors influencing perception of menstrual blood loss volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12836723" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Abnormal uterine bleeding in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7770270" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2400752" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Assessment of menstrual blood loss using a pictorial chart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27028334" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22866673" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Quantifying the PBAC in a pediatric and adolescent gynecology population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15748930" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Menstrual disorders in the college age female.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15167821" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27829537" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Menstrual questionnaires for clinical and research use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sexually Transmitted Infections Treatment Guidelines, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23281358" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Menstrual disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16275228" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12093932" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dysfunctional uterine bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16171484" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Bleeding disorders in teenagers presenting with menorrhagia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10384806" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Menstrual disorders. Dysfunctional uterine bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22946701" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22933528" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14724769" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Abnormal bleeding in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11391329" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Bleeding disorders: A common cause of menorrhagia in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9526820" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Menorrhagia in adolescents requiring hospitalization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15266996" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Coagulation disorders as the cause of menorrhagia in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12049298" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Hematological abnormalities in adolescent menorrhagia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25256871" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hemostatic abnormalities in young females with heavy menstrual bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7837120" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Dysfunctional uterine bleeding in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31441825" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32573942" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6970521" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Acute adolescent menorrhagia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30472382" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding: The Queensland Statewide Paediatric and Adolescent Gynaecology Service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23005346" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27429530" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Evaluation of the Hemostatic Disorders in Adolescent Girls with Menorrhagia: Experiences from a Tertiary Referral Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35917902" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : High Prevalence of Congenital Factor VII (FVII) Deficiency in Adolescent Females with Heavy Menstrual Bleeding and Iron Deficiency Anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31624107" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15198765" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : von Willebrand disease in women with menorrhagia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17106950" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Gynaecological and obstetric management of women with inherited bleeding disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27262832" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Iron Deficiency without Anemia: A Common Yet Under-Recognized Diagnosis in Young Women with Heavy Menstrual Bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15306670" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Treatment of von Willebrand's Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22840932" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24264714" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Committee Opinion No.580: von Willebrand disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17430500" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Association between Chlamydia trachomatis and abnormal uterine bleeding.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
